Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Return on Equity (2016 - 2025)

Biomerica's Return on Equity history spans 15 years, with the latest figure at 0.84% for Q4 2025.

  • For Q4 2025, Return on Equity rose 23.0% year-over-year to 0.84%; the TTM value through Nov 2025 reached 0.84%, up 23.0%, while the annual FY2025 figure was 0.93%, 28.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.84% at Biomerica, down from 0.79% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.5% in Q2 2022 and bottomed at 1.34% in Q3 2021.
  • The 5-year median for Return on Equity is 0.83% (2024), against an average of 0.88%.
  • The largest annual shift saw Return on Equity tumbled -103bps in 2021 before it skyrocketed 76bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 1.3% in 2021, then skyrocketed by 45bps to 0.71% in 2022, then increased by 16bps to 0.59% in 2023, then tumbled by -81bps to 1.07% in 2024, then increased by 22bps to 0.84% in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Return on Equity are 0.84% (Q4 2025), 0.79% (Q3 2025), and 1.03% (Q2 2025).